INHIBRX BIOSCIENCES INC

Ticker: INBX CUSIP: 45720N103 Class: Common Stock

MetLife Investment Management, LLC's Holding History (CIK: 0001529735)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 5,320 Value ($000) $420 Avg Close $68.13 Range $28.16 - $94.56

Q3 2025

Shares 7,425 Value ($000) $250 Avg Close $24.62 Range $13.97 - $33.98

Q2 2025

Shares 7,683 Value ($000) $110 Avg Close $12.93 Range $10.80 - $15.84

Q1 2025

Shares 7,683 Value ($000) $107 Avg Close $13.58 Range $11.68 - $16.83

Q4 2024

Shares 7,683 Value ($000) $118 Avg Close $15.23 Range $12.25 - $17.41

Q3 2024

Shares 5,857 Value ($000) $92 Avg Close $14.05 Range $10.80 - $17.79

Q2 2024

Shares 4,823 Value ($000) $68 Avg Close $15.62 Range $11.64 - $18.95

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	5,320	$420	$68.13	$28.16 - $94.56
Q3 2025	7,425	$250	$24.62	$13.97 - $33.98
Q2 2025	7,683	$110	$12.93	$10.80 - $15.84
Q1 2025	7,683	$107	$13.58	$11.68 - $16.83
Q4 2024	7,683	$118	$15.23	$12.25 - $17.41
Q3 2024	5,857	$92	$14.05	$10.80 - $17.79
Q2 2024	4,823	$68	$15.62	$11.64 - $18.95